Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis
- 1 January 2003
- Vol. 111 (1), 1-11
- https://doi.org/10.1034/j.1600-0463.2003.11101031.x
Abstract
Based on a well established association between testicular cancer and undescended testis and more recent publications on epidemiological links between these disorders and male infertility, we proposed the existence of a testicular dysgenesis syndrome (TDS). In most cases TDS presents with impaired spermatogenesis, only in rare cases the full range of its signs, including genital malformations and testicular cancer can be seen in one patient. In order to further corroborate our hypothesis about the presence of testicular dysgenesis in patients with testicular abnormalities, we decided to re-analyse recent testicular biopsies derived from patients with infertility, hypospadias and undescended testis. We searched for histological signs of testicular dysgenesis: microliths, Sertoli-cell-only tubules, immature seminiferous tubules with undifferentiated Sertoli cells, and tubules containing carcinoma in situ (CIS) cells. We identified 20 patients who fulfilled the histological criteria for testicular dysgenesis, 9 of whom were diagnosed with uni- or bilateral testicular germ cell neoplasia, and the remaining ones with subfertility. The presence of CIS was detected in 5 patients (3 of them with overt contralateral germ cell tumours). In all but one of the CIS cases, at least one additional sign of testicular dysgenesis was detected. Clinical records of all patients were subsequently analysed. The majority of cases had oligozoospermia or azoospermia. Their reproductive hormone profiles correlated with the results of semen sampling and testicular histology. In conclusion, our study of 20 patients with various reproductive abnormalities provided evidence that TDS is a real clinical entity. We speculate that most of these abnormalities are caused by adverse environmental effects rather than specific gene mutations.Keywords
This publication has 39 references indexed in Scilit:
- Syndromic aspects of testicular carcinomaCancer, 2003
- Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour developmentAPMIS, 2003
- Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue SamplesJournal of Clinical Endocrinology & Metabolism, 1999
- RISK FACTORS FOR CRYPTORCHIDISM AND HYPOSPADIASJournal of Urology, 1999
- RISK FACTORS FOR CRYPTORCHIDISM AND HYPOSPADIASJournal of Urology, 1999
- Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish MenJournal of Clinical Endocrinology & Metabolism, 1997
- Quantitative Histology of Germ Cells in the Undescended Testes of Human Fetuses, Neonates and InfantsJournal of Urology, 1995
- Testicular cancer in nine northern european countriesInternational Journal of Cancer, 1994
- Testicular biopsy as an outpatient procedure in screening for carcinoma-in-situ: complications and the patient's acceptanceInternational Journal of Andrology, 1987
- Screening for carcinoma‐in‐situ of the testisInternational Journal of Andrology, 1987